Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Drug Deliv Transl Res. 2021 Jun;11(3):927–943. doi: 10.1007/s13346-020-00802-8

Fig. 4:

Fig. 4:

In-vitro deposition profile of AFA-NP. a. Aerosol dispersion performance as % deposited on each stage of the Next Generation Impactor™ (NGI™) for AFA-NP. For Q = 15 L/minute for 4min. The effective cutoff diameters (D50) for each impaction stage are as follows: stage 1 (14.1 μm), stage 2 (8.61 μm), stage 3 (5.39 μm), stage 4 (3.3 μm), stage 5 (2.08 μm), stage 6 (1.36 μm), and stage 7 (0.98 μm). (n=3, average ± SD). b. Cumulative % deposition plot representing cumulative % of particles deposited at each stage. c. Aerosolization properties of AFA-NP. Data represent mean±SD (n=3).